Mechanistic reasoning and informed consent

Evidence-based medicine (EBM) proponents have argued that mechanistic evidence concerning medical treatments should be considered secondary to evidence derived from randomized controlled trials (RCTs). One common criticism of RCTs is that they often do not yield results that are generalizable to cli...

Full description

Saved in:  
Bibliographic Details
Authors: Kennedy, Ashley (Author) ; Malanowski, Sarah (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Wiley-Blackwell [2019]
In: Bioethics
Year: 2019, Volume: 33, Issue: 1, Pages: 162-168
IxTheo Classification:NCH Medical ethics
Further subjects:B Informed Consent
B shared decision-making
B Birth Control
B mechanisms
Online Access: Presumably Free Access
Volltext (Verlag)
Volltext (doi)

MARC

LEADER 00000caa a22000002 4500
001 1727524233
003 DE-627
005 20230426130555.0
007 cr uuu---uuuuu
008 200820s2019 xx |||||o 00| ||eng c
024 7 |a 10.1111/bioe.12500  |2 doi 
035 |a (DE-627)1727524233 
035 |a (DE-599)KXP1727524233 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Kennedy, Ashley  |e VerfasserIn  |4 aut 
245 1 0 |a Mechanistic reasoning and informed consent 
264 1 |c [2019] 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Evidence-based medicine (EBM) proponents have argued that mechanistic evidence concerning medical treatments should be considered secondary to evidence derived from randomized controlled trials (RCTs). One common criticism of RCTs is that they often do not yield results that are generalizable to clinical practice, and that for clinical practice application, mechanistic evidence is needed. However, proponents of EBM have argued that mechanistic reasoning is often unreliable and thus not very useful. Here we suggest an important role of mechanistic explanation that has been left out of this discussion entirely, namely, its importance in a patient’s decision of whether or not to take certain drugs. We argue that in certain cases, knowing how a treatment works is just as important for the patient as knowing whether it does. In this paper, we explore how and why giving patients mechanistic information can be an important factor in obtaining informed consent for medical treatment, focusing on the example case of hormonal contraceptives. 
650 4 |a Birth Control 
650 4 |a Informed Consent 
650 4 |a mechanisms 
650 4 |a shared decision-making 
652 |a NCH 
700 1 |a Malanowski, Sarah  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Bioethics  |d Oxford [u.a.] : Wiley-Blackwell, 1987  |g 33(2019), 1, Seite 162-168  |h Online-Ressource  |w (DE-627)271596708  |w (DE-600)1480658-7  |w (DE-576)078707986  |x 1467-8519  |7 nnns 
773 1 8 |g volume:33  |g year:2019  |g number:1  |g pages:162-168 
856 |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bioe.12500  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via free article)] 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12500  |x Verlag 
856 |u https://doi.org/10.1111/bioe.12500  |x doi  |3 Volltext 
936 u w |d 33  |j 2019  |e 1  |h 162-168 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 3741326720 
LOK |0 003 DE-627 
LOK |0 004 1727524233 
LOK |0 005 20210908165359 
LOK |0 008 200820||||||||||||||||ger||||||| 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo 
LOK |0 936ln  |0 1550736558  |a NCH 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw